Clinical trials
Phase 4 Essential Hypertension trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2021 | 1 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Unknown status | 5 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Shyndec Pharmaceutical Co., Ltd. | 2 |
| Beijing Anzhen Hospital | 1 |
| Chinese Academy of Medical Sciences, Fuwai Hospital | 1 |
| Hansung University | 1 |
| Jiangsu Simcere Pharmaceutical Co., Ltd. | 1 |
| Marubeni Pharmaceuticals (Suzhou) Co., Ltd. | 1 |
| Shenzhen Ausa Pharmed Co.,Ltd | 1 |
| Sichuan Academy of Medical Sciences | 1 |
| Takeda | 1 |
| Third Military Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Essential Hypertension | 13 |
| Hypertension | 4 |
| Diabetes Mellitus, Type 2 | 2 |
| Coronary Disease | 1 |
| Hyperuricemia | 1 |
| Kidney Diseases | 1 |
| Multiple Endocrine Neoplasia Type 1 | 1 |
| Stroke | 1 |
| Vascular Remodeling | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.